Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novabay Pharmaceuticals (NY: NBY ) 2.000 -0.020 (-0.99%) Official Closing Price Updated: 8:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novabay Pharmaceuticals < Previous 1 2 3 4 5 6 7 Next > NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions July 28, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com July 21, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event July 15, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America July 07, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals: Q1 Earnings Insights May 12, 2022 NovaBay Pharmaceuticals (AMEX:NBY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results May 12, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire Earnings Outlook For NovaBay Pharmaceuticals May 11, 2022 NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations May 09, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12 May 05, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals CEO Issues Letter to Stockholders April 25, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 21, 2022 Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! Via InvestorPlace 26 Stocks Moving in Thursday's Pre-Market Session April 21, 2022 Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:... Via Benzinga 23 Stocks Moving in Tuesday's Pre-Market Session April 19, 2022 Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss. Sharps Technology, Inc. (NASDAQ: STSS... Via Benzinga NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor’s Eczema Treatment April 11, 2022 From NovaBay Pharmaceuticals, Inc Via Business Wire NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line April 01, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals's Return On Capital Employed Insights March 30, 2022 According to Benzinga Pro data, during Q4, NovaBay Pharmaceuticals (AMEX:NBY) posted sales of $2.64 million. Earnings were up 93.1%, but NovaBay Pharmaceuticals still reported an overall loss of... Via Benzinga NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results March 29, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia March 29, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga NovaBay Pharmaceuticals Earnings Preview March 28, 2022 NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that NovaBay... Via Benzinga Earnings Scheduled For March 29, 2022 March 29, 2022 Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million. Via Benzinga NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29 March 22, 2022 From NovaBay® Pharmaceuticals, Inc. Via Business Wire The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More March 27, 2022 Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 18, 2022 Good morning, trader! Let's start off the final day of the workweek right with a breakdown of the biggest pre-market stock movers for Friday! Via InvestorPlace 25 Stocks Moving in Friday's Pre-Market Session March 18, 2022 Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 60.5% to $1.53 in pre-market trading. StoneCo Ltd. (NASDAQ: STNE) shares rose 23.7% to $11.90 in pre-market trading... Via Benzinga NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest February 28, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China February 23, 2022 From NovaBay Pharmaceuticals, Inc Via Business Wire NovaBay Pharmaceuticals Announces Changes to Its Board of Directors January 28, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks January 20, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders January 20, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms January 10, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.